
structural formula
| business number | 0184 |
|---|---|
| molecular formula | c8h9no2 |
| molecular weight | 151.17 |
| label |
p-aminomethylbenzoic acid |
numbering system
cas number:56-91-7
mdl number:mfcd00010203
einecs number:200-297-9
rtecs number:none
brn number:1100606
pubchem number:24846170
physical property data
1. character: hydrate it is white scaly or crystalline powder. odorless, slightly bitter taste.
2. density (g/ml,25/4℃) : undetermined
3. relative vapor density (g/ml,air=1): undetermined
4. melting point (ºc): 340-350
5. boiling point (ºc,normal pressure): undetermined
6. boiling point (ºc,5.2kpa): undetermined
7. refractive index: not ok
8. flashpoint (ºc): undetermined
9. specific optical rotation ( º): undetermined
10. spontaneous ignition point or ignition combustion temperature (ºc): not ok
11. vapor pressure (kpa,25ºc): undetermined
12. saturated vapor pressure ( kpa,60ºc): undetermined
4. surface tension (dyne/cm):57.1
5. polarizability(10-24cm3):16.50
calculate chemical data
1. reference value for hydrophobic parameter calculation (xlogp): none
2. number of hydrogen bond donors: 2
3. number of hydrogen bond acceptors: 3
4. number of rotatable chemical bonds: 2
5. number of tautomers: none
6. topological molecule polar surface area 63.3
7. number of heavy atoms: 11
8. surface charge: 0
9. complexity: 139
10. number of isotope atoms: 0
11. determine the number of atomic stereocenters: 0
12. uncertain number of atomic stereocenters: 0
13. determine the number of chemical bond stereocenters: 0
14. number of uncertain chemical bond stereocenters: 0
15. number of covalent bond units: 1
properties and stability
none yet
storage method
this product should be kept sealed.
synthesis method
there are three processes: (1) is derived from the catalytic hydrogenation of p-cyanobenzoic acid; (2) aminated from p-chloromethylbenzoic acid and get; (3 ) is derived from the amination of p-bromomethylbenzoic acid.
purpose
organic synthesis intermediates. hemostatic drugs and fibrinolytic inhibitors are suitable for various diseases caused by excessive fibrinolytic enzyme activity.
-fareast-language: zh-cn; mso-bidi-language: ar-sa”>3) is derived from the amination of p-bromomethylbenzoic acid.
purpose
organic synthesis intermediates. hemostatic drugs and fibrinolytic inhibitors are suitable for various diseases caused by excessive fibrinolytic enzyme activity.

微信扫一扫打赏
